Krzysztof Małyszczak

Krzysztof Małyszczak

Auto-generated profile, based on publicly available information

Krzysztof Małyszczak

Department of Psychiatry, Division of Psychotherapy and Psychosomatic Medicine, Wroclaw Medical University, Wroclaw, Poland

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 April 2009 in Psycho-Oncology
Verified
Journal Article
Open access
PDF file
ACAngelika Chachaj
Angelika Chachaj
KMKrzysztof Małyszczak
Krzysztof Małyszczak
KPKrystian Pyszel
Krystian Pyszel
JLJoanna Lukas
Joanna Lukas
RTRadosław Tarkowski
Radosław Tarkowski
ASAndrzej Szuba
Andrzej Szuba
Objective: The aim of the study was to identify factors associated with worse physical and emotional functioning of breast cancer survivors with upper extremity lymphedema.Methods: 1250 sets of questionnaires consisting of WHO‐DAS II, EORTC QLQ‐C30, EORTC QLQ‐BR23 and GHQ‐30 were mailed to women who underwent a breast cancer surgery at the Lower Silesian Oncology Center in Poland between January 1998 and December 2005.Results and conclusions: The response rate was 33.47%. 117 women were included into a lymphedema group and 211 into a group without this complication. Women with lymphedema were more disabled (overall disability (DAS) score 39.78 versus 34.67; p<0.001), reported symptoms from the upper extremity (shoulder or arm pain and difficulties in arm movement) and from the operated breast (pain and swelling) 2–3 times more often, experienced poorer quality of life (global quality of life (QOL) score 0.50 versus 0.57; p=0.005) and higher psychological distress (GHQ score 10.61 versus 8.01; p=0.007) in comparison to breast cancer survivors without lymphedema. The factors associated with higher DAS score, higher GHQ score and lower QOL score in women with lymphedema were as following: pain in the upper limb (mainly shoulder and arm), pain in operated breast, difficulties with arm movement, localization of lymphedema within the hand or in operated breast, a history of dermatolymphangitis and of receiving chemotherapy. Severity of lymphedema, younger age, BMI and localization of lymphedema within the dominant limb were not considerably related to worse outcomes in these women. Copyright © 2009 John Wiley & Sons, Ltd.

1 October 2013 in Journal of Hepatology
Verified
Journal Article
Closed access
JBJoanna Bladowska
Joanna Bladowska
AZAnna Zimny
Anna Zimny
BKBrygida Knysz
Brygida Knysz
KMKrzysztof Małyszczak
Krzysztof Małyszczak
AKAnna Kołtowska
Anna Kołtowska
MSMarek J. Sąsiadek
Marek J. Sąsiadek

1 June 2014 in Journal of Clinical Virology
Verified
Journal Article
Closed access
TPTomasz Pawlowski
Tomasz Pawlowski
MRMieczyslaw Radkowski
Mieczyslaw Radkowski
KMKrzysztof Małyszczak
Krzysztof Małyszczak
MIMałgorzata Inglot
Małgorzata Inglot
MZMałgorzata Zalewska
Małgorzata Zalewska
TLTomasz Laskus
Tomasz Laskus

11 July 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JBJoanna Bladowska
Joanna Bladowska
BKBrygida Knysz
Brygida Knysz
AZAnna Zimny
Anna Zimny
KMKrzysztof Małyszczak
Krzysztof Małyszczak
AKAnna Kołtowska
Anna Kołtowska
MSMarek J. Sąsiadek
Marek J. Sąsiadek
Asymptomatic central nervous system (CNS) involvement occurs in the early stage of the human immunodeficiency virus (HIV) infection. It has been documented that the hepatitis C virus (HCV) can replicate in the CNS. The aim of the study was to evaluate early disturbances in cerebral microcirculation using magnetic resonance (MR) perfusion-weighted imaging (PWI) in asymptomatic HIV-1-positive and HCV-positive patients, as well as to assess the correlation between PWI measurements and the clinical data. Fifty-six patients: 17 HIV-1-positive non-treated, 18 HIV-1-positive treated with combination antiretroviral therapy (cART), 7 HIV-1/HCV-positive non-treated, 14 HCV-positive before antiviral therapy and 18 control subjects were enrolled in the study. PWI was performed with a 1.5T MR unit using dynamic susceptibility contrast (DSC) method. Cerebral blood volume (CBV) measurements relative to cerebellum (rCBV) were evaluated in the posterior cingulated region (PCG), basal ganglia (BG), temporoparietal (TPC) and frontal cortices (FC), as well as in white matter of frontoparietal areas. Correlations of rCBV values with immunologic data and liver histology activity index (HAI) were analyzed. Significantly lower rCBV values were found in the right TPC and left FC as well as in PCG in HIV-1-positive naïve (p = 0.009; p = 0.020; p = 0.012), HIV-1 cART treated (p = 0.007; p = 0.009; p = 0.033), HIV-1/HCV-positive (p = 0.007; p = 0.027; p = 0.045) and HCV-positive patients (p = 0.010; p = 0.005; p = 0.045) compared to controls. HIV-1-positive cART treated and HIV-1/HCV-positive patients demonstrated lower rCBV values in the right FC (p = 0.009; p = 0.032, respectively) and the left TPC (p = 0.036; p = 0.005, respectively), while HCV-positive subjects revealed lower rCBV values in the left TPC region (p = 0.003). We found significantly elevated rCBV values in BG in HCV-positive patients (p = 0.0002; p<0.0001) compared to controls as well as to all HIV-1-positive subjects. There were no significant correlations of rCBV values and CD4 T cell count or HAI score. PWI examination enables the assessment of HIV-related as well as HCV-related early cerebral dysfunction in asymptomatic subjects. HCV-infected patients seem to reveal the most pronounced perfusion changes.

1 November 2018 in Psychoneuroendocrinology
Verified
Journal Article
Closed access
TPTomasz Pawłowski
Tomasz Pawłowski
KMKrzysztof Malyszczak
Krzysztof Malyszczak
MIMałgorzata Inglot
Małgorzata Inglot
MZMałgorzata Zalewska
Małgorzata Zalewska
MRMieczyslaw Radkowski
Mieczyslaw Radkowski
Dariusz PawlakDariusz Pawlak
Dariusz Pawlak

13 February 2024 in Advances in Clinical and Experimental Medicine
Verified
Journal Article
Open access
ACAngelika Chachaj
Angelika Chachaj
MJMałgorzata Jeziorek
Małgorzata Jeziorek
IDIlona Dudka
Ilona Dudka
MSMonika Sowicz
Monika Sowicz
AAAgnieszka Adaszyńska
Agnieszka Adaszyńska
ASAndrzej Szuba
Andrzej Szuba
Lipedema is characterized by the painful abnormal deposition of adipose tissue in the lower limbs and is often misdiagnosed as obesity. Considering the numerous bothersome physical symptoms of lipedema, women with lipedema may have greater disability and emotional problems than women with lifestyle-induced obesity. Our study aims to assess disability, anxiety and depression symptoms in women with lipedema compared to women with overweight/obesity. Women with lipedema (n = 45, with a mean age of 41 years) and women who are overweight/obese (n = 43, with a mean age of 44.95 years) were asked to complete the following questionnaires: The World Health Organization Disability Assessment Schedule (WHO-DAS II), Beck's Depression Inventory - II (BDI-II), and The Hospital Anxiety and Depression Scale (HADS). Despite the higher BMI in the overweight/obesity group, the group with lipedema was more disabled in numerous domains of the WHO-DAS II questionnaire, including Life activities - domestic, work and school responsibilities and Participation in society When the influence of BMI was adjusted, a difference in the domain of Mobility was also present. The study groups did not differ in anxiety and depression symptoms. We showed that behavioral impairment was the main factor affecting functioning in women with lipedema. Emotional symptoms did not differentiate the study groups. Leg volumes and adipose tissue pain intensity were associated with greater disability in women with lipedema, and should be considered in managing women with this condition and in future research estimating the effectiveness of lipedema treatment.